Candel Therapeutics, Inc. (CADL) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Cash from Operations | -18.04M | -10.57M | -10.24M | -8.89M | -8.62M | -5.81M | -6.57M | -6.2M | -8.44M | -7.42M | -8.81M | -7.2M | -10.82M | -6.88M | -9.38M | -7.1M | -8.05M | -5.24M | -6.89M | -4.46M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | -22209.68% | -30270.97% | -22893.55% | -25977.42% | -16896.77% | -22238.71% | -14383.87% |
| Operating CF Growth % | -109.34% | -81.77% | -55.73% | -43.45% | -2.11% | 21.67% | 25.37% | 13.86% | 22.01% | -7.8% | 6.14% | -1.38% | -34.35% | -31.44% | -36.12% | -59.16% | -43.11% | -53.34% | - | - |
| Net Income | -8.86M | -29.5M | -11.27M | -4.8M | 7.38M | -14.07M | -10.65M | -22.24M | -8.22M | -11.1M | -8.44M | -9.61M | -8.79M | -5.08M | -8.69M | -4.15M | -874K | 1.6M | -16.16M | -17.08M |
| Depreciation & Amortization | 149K | 163K | 195K | 242K | 245K | 245K | 245K | 249K | 251K | 335K | 245K | 236K | 230K | 221K | 205K | 187K | 165K | 178K | 21K | 7K |
| Stock-Based Compensation | 0 | 1.29M | 1.16M | 1.05M | 314K | 1.24M | 1.18M | 1.84M | 1.04M | 939K | 686K | 733K | 733K | 634K | 743K | 438K | 492K | -446K | 1.91M | 1.07M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -416K | -144K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -5.75M | 13.88M | -681K | -5.45M | -14.73M | 6.03M | 1.8M | 13.51M | 171K | 818K | 170K | 163K | -492K | -2.59M | -199K | -4.81M | -8.18M | -8.63M | 8.27M | 11.92M |
| Working Capital Changes | -3.57M | 3.6M | 356K | 67K | -1.82M | 743K | 844K | 441K | -1.68M | 1.58M | -1.06M | 1.43M | -2.5M | -71K | -1.45M | 1.24M | 347K | 2.06M | -932K | -379K |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 1.7M | 33K | -744K | 1.01M | 507K | -56K | -140K | -39K | 50K | 0 | -214K | -62K | 149K | -544K | -508K | 418K | -579K | 665K | 181K | -350K |
| Cash from Investing | -675K | -409K | -117K | -31K | -3K | -3K | 0 | -6K | -7K | -27K | -103K | -169K | 19K | -276K | -215K | -635K | -171K | -504K | -392K | -710K |
| Capital Expenditures | -675K | -409K | -144K | -31K | -3K | -3K | 0 | -6K | -7K | -47K | -103K | -169K | -138K | -276K | -215K | -635K | -171K | -504K | -392K | -710K |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | 890.32% | 693.55% | 2048.39% | 551.61% | 1625.81% | 1264.52% | 2290.32% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 27K | 0 | 0 | 0 | 0 | 0 | 0 | 20K | 0 | 0 | 157K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 93.81M | 43.9M | -3.37M | 17.44M | -1.87M | 91.91M | 1.68M | 1.95M | -1.25M | -121K | 0 | 0 | 0 | 36K | 0 | 22K | 19.92M | 0 | 71.36M | 333K |
| Debt Issued (Net) | 0 | 7.5M | -2.5M | -2.5M | -2.5M | -2.5M | -2.5M | -2.5M | -1.67M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 19.91M | 0 | 0 | 0 |
| Equity Issued (Net) | 93.81M | 4K | -713K | 19.7M | 384K | 94.04M | 4.07M | 3.46M | 186K | -121K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -121K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 36.39M | -158K | 246K | 246K | 370K | 103K | 990K | 226K | 0 | 0 | 0 | 0 | 36K | 0 | 22K | 6K | 0 | 71.36M | 333K |
| Net Change in Cash | 75.1M | 32.92M | -13.72M | 8.52M | -10.49M | 86.1M | -4.9M | -4.26M | -9.7M | -7.57M | -8.91M | -7.36M | -10.8M | -7.13M | -9.6M | -7.71M | 11.69M | -5.74M | 64.07M | -4.84M |
| Free Cash Flow | -18.71M | -10.98M | -10.38M | -8.92M | -8.62M | -5.82M | -6.57M | -6.2M | -8.45M | -7.47M | -8.91M | -7.36M | -10.96M | -7.16M | -9.6M | -7.73M | -8.22M | -5.74M | -7.29M | -5.17M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | -23100% | -30964.52% | -24941.94% | -26529.03% | -18522.58% | -23503.23% | -16674.19% |
| FCF Growth % | -117.1% | -88.71% | -57.92% | -43.81% | -2.06% | 22.12% | 26.24% | 15.75% | 22.93% | -4.3% | 7.17% | 4.76% | -33.23% | -24.71% | -31.75% | -49.58% | -40.44% | -48.41% | - | - |
| FCF per Share | -0.30 | -0.20 | -0.19 | -0.17 | -0.27 | -0.16 | -0.21 | -0.21 | -0.29 | -0.26 | -0.31 | -0.25 | -0.38 | -0.25 | -0.33 | -0.27 | -0.29 | -0.25 | -0.31 | -0.21 |
| FCF Conversion (FCF/Net Income) | 2.04x | 0.36x | 0.91x | 1.85x | -1.17x | 0.41x | 0.62x | 0.28x | 1.03x | 0.67x | 1.04x | 0.75x | 1.23x | 1.35x | 1.08x | 1.71x | 9.21x | -3.28x | 0.43x | 0.26x |
| Interest Paid | 0 | -571K | 127K | 192K | 252K | 333K | 421K | 0 | 549K | 556K | 555K | 537K | 500K | 309K | 515K | 211K | 117K | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -168K | 168K | 0 | 27K | 23K | 48K | 85K | 1K | 7K | 15K |